IMCR
Immunocore Holdings plc
$32.00
+$0.04(+0.13%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$1.54B
Volume
356.64K
52W Range
$23.15 - $40.72
Target Price
$63.85
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Mar | 2024 Sep | 2024 Dec | 2025 Mar |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $174.4M | $199.9M | $70.5M | $80.2M | $242.1M | $93.9M | ||
| Total Revenue | $174.4M | $199.9M | $70.5M | $80.2M | $242.1M | $93.9M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $1.1M | $835.0K | $246.0K | $448.0K | $2.5M | $831.0K | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $173.3M | $199.1M | $70.3M | $79.8M | $239.6M | $93.0M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $225.0M | $254.1M | $96.7M | $88.3M | $294.7M | $96.7M | ||
| Research & Development | $101.9M | $129.6M | $57.5M | $52.8M | $172.0M | $56.5M | ||
| Research Expense | $101.9M | $129.6M | $57.5M | $52.8M | $172.0M | $56.5M | ||
| Selling, General & Administrative | $123.1M | $124.5M | $39.3M | $35.5M | $122.7M | $40.2M | ||
| Selling & Marketing Expenses | -- | $124.5M | -- | -- | $122.7M | -- | ||
| General & Administrative Expenses | $123.1M | $144.5M | $39.3M | $35.5M | -- | $40.2M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-51.7M | $-55.0M | $-26.5M | $-8.5M | $-55.1M | $-3.6M | ||
| EBITDA | -- | -- | $-14.6M | $10.4M | $-18.3M | $10.0M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $5.4M | $6.4M | $3.2M | $4.3M | $24.2M | $3.0M | ||
| Intinc | $3.8M | $14.3M | $8.2M | $6.0M | $31.4M | $4.2M | ||
| Net Non-Operating Interest Income/Expense | $-1.7M | $7.9M | $5.0M | $1.7M | $7.2M | $1.2M | ||
| Other Income/Expense | $1.7M | $897.0K | $-190.0K | $-9.0M | -- | $-5.5M | ||
| Other Special Charges | $-1.7M | $-897.0K | $190.0K | $9.0M | -- | $5.5M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | -- | -- | $-15.6M | $10.4M | $-23.7M | $9.1M | ||
| Pre-Tax Income | $-40.9M | $-47.1M | $-18.9M | $6.1M | $-48.0M | $6.1M | ||
| INCOME TAX | ||||||||
| Tax Provision | $11.7M | $5.9M | $357.0K | $-2.6M | $7.5M | $1.1M | ||
| NET INCOME | ||||||||
| Net Income | $-52.5M | $-53.0M | $-19.2M | $8.7M | $-55.4M | $5.0M | ||
| Net Income (Continuing Operations) | $-52.5M | $-53.0M | $-19.2M | $8.7M | $-55.4M | $5.0M | ||
| Net Income (Discontinued Operations) | $-52.5M | $-53.0M | $-19.2M | $8.7M | $-55.4M | $5.0M | ||
| Net Income (Common Stockholders) | $-52.5M | $-53.0M | $-19.2M | $8.7M | $-55.4M | $5.0M | ||
| Normalized Income | -- | -- | $-18.7M | $3.5M | $-47.5M | $6.0M | ||
| TOTALS | ||||||||
| Total Expenses | $226.1M | $254.9M | $97.0M | $88.8M | $297.2M | $97.5M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $45.7M | $48.9M | $49.9M | $50.0M | $50.0M | $50.1M | ||
| Average Shares Outstanding (Diluted) | $45.7M | $48.9M | $49.9M | $52.8M | $50.0M | $51.9M | ||
| Shares Outstanding | $48.1M | $48.1M | $50.0M | $50.0M | $50.1M | $50.2M | ||
| Basic EPS | $-1.15 | $-0.84 | $-0.49 | $0.17 | $-1.11 | $0.10 | ||
| Basic EPS (Continuing Operations) | $-1.15 | $-0.84 | $-0.49 | $0.17 | $-1.11 | $0.10 | ||
| Diluted EPS | $-1.15 | $-0.84 | $-0.49 | $0.17 | $-1.11 | $0.10 | ||
| Diluted EPS (Continuing Operations) | $-1.15 | $-0.84 | $-0.49 | $0.17 | $-1.11 | $0.10 | ||
| OTHER METRICS | ||||||||
| Other Costof Revenue | $1.1M | $835.0K | $246.0K | $448.0K | $2.5M | $831.0K | ||
| Other Gand A | $123.1M | $144.5M | $39.3M | $35.5M | -- | $40.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMCR | $32.00 | +0.1% | 356.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |